期刊文献+

刺五加叶皂甙预处理对供心保存的实验研究 被引量:9

Improvement of Donor Heart Storage by Acanthopanax Senticosus Saponins Pretreatment
下载PDF
导出
摘要 目的观察刺五加叶皂甙 (ASS)预处理对供心保存效果的影响 ,并探讨其机制。方法随机将兔分为对照组 (Control组 ) ;缺血预处理组(IP组) ;ASS预处理组 (ASS组 ) ;格列苯脲加ASS预处理组(Gli+ASS组 ) ;格列苯脲组 (Gli组 )。先行药物预处理 ,再离体灌注 ,停搏 ,4℃保存180min,最后行再灌注。观察心功能 (±dp/dtmax及其恢复率 )、心肌磷酸肌酸激酶 (CK -mb)释放量、心肌ATP含量和能荷(EC)。结果①与Control组比较 ,IP组和ASS组的±dp/dtmax恢复率均增加 ,CK -mb均降低 ,停搏180min的ATP及EC均提高 (P<0.05或P<0.01) ;②Gli+ASS组和Gli组分别与Control组比较 ,±dp/dtmax恢复率 ,CK -mb ,ATP和EC均无明显差异 (P>0.05) ;③Gli+ASS组与ASS组比较 ,±dp/dtmax恢复率 ,CK -mb,停搏180min的ATP、EC差异明显(P<0.05)。结论ASS预处理供心可以发挥和缺血预处理相似的心脏保护作用。开放KATP 是ASS发挥药物预处理作用的重要机制之一。 Objective To observe the effect of Acanthopanax senticosus saponins(ASS)pretreatment on donor heart hypothermic storage and discuss cardioprotection mechanism of ASS pretreatment.Methods Rabbits were randomly divided into five groups:control group was subjected to Langendorff perfusion only;ischemic preconˉditioning group(IP group)was given2cycles of2.5min ischemia followed by5min reperfusion;ASS pretreatment group(ASS group)was given ASS pretreatment,then subjected to Langendorff perfusion;glibenclamide and ASS pretreatment group(Gli+ASS group)was given glibenclamide first,then gained ASS pretreatment and Langendorff perfusion;glibenclamide group(Gli group)was given glibenclamide first,then subjected to Langendorff perfusion.All hearts were subsequently arrested by administrating St.ThomasⅡcardioplegic solution and stored at4℃for180min.Finally,hearts of five groups were reperfused by normothermic Langendorff perfusion.Heart function paˉrameters(±dp/dt max and their recovery percentage),myocardial CK_mb leakage,myocardial content of ATP and energy charge(EC)were determined.Results①Compared with control group,±dp/dt max recovery percentage inˉcreased,CK-mb decreased,ATP and EC increased in IP group following180min hypothermic storage;②Both Gli+ASS group and Gli group were similar to control group in±dp/dt max,CK_mb,ATP and EC(P>0.05);③Gli+ASS group was differnt from ASS group in±dp/dt max,CK_mb,ATP and EC following180min hypotherˉmic storage(P<0.05).Conclusions ASS pretreatment on donor heart can exert similar cardioprotection as IP.Opening ATP sensitive potassium channel is one of the important mechanisms of pharmacological pretreatment of ASS.
出处 《中国微循环》 北大核心 2005年第1期30-33,共4页 Journal of Chinese Microcirculation
关键词 刺五加叶皂甙 预处理 供心保存 Acanthopanax senticosus saponins Pretreatment Heart preservation
  • 相关文献

参考文献12

  • 1张玉华,韩丛成,曲绍春,于晓风,睢大员.刺五加叶皂苷对大鼠实验性心肌梗死的保护作用[J].中国新药杂志,2002,11(9):695-697. 被引量:31
  • 2王程,修瑞娟.心肌的预适应及应用前景[J].中国微循环,2002,6(5):265-268. 被引量:3
  • 3范丽静,蒋晓红,姚国恩.刺五加注射液的研究进展[J].中成药,2003,25(6):488-490. 被引量:37
  • 4朱水波,孙宗全,殷桂林,王荣平,刘勇.腺苷A_1受体触发延迟预处理对兔心保存的实验研究[J].中国微循环,2003,7(4):230-231. 被引量:3
  • 5Zhang ZW, Kaneda T, Ku K, et al.Ischemic preconditioning and nicorandil pretreatment improve donor heart preservation[J].Jpn Circ J.2001, 65(7):678~ 682
  • 6Kevelaitis E, Oubenaissa A, Peynet J, et al.Preconditioning by mitochondrial ATP-sensitive potassium channel openers:an effective approach for improving the preservation of heart transplants[J].Circulation.1999, 100(II):345~ 350
  • 7Hamada K, Yamazaki J,Nagao T.Shortening of action potential duration is not prerequite for cardiac protection by ischemic preconditioning or a KATP channel opener[J].J Mol Cell Cardiol.1998,30(7):1369~ 1379
  • 8Sato T, Sasaki N, O'Rourke B, et al.Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels[J].J Am Coll Cardiol.2000, 35(2):514~ 518
  • 9Sato T, Li Y,Saito T,et al.Minoxidil opens mitochondrial KATP channels and confers cardioprotection[J].British Journal of Pharmacology.2004, 141(2):360~ 366
  • 10Laclau MN, Boudina S, Thambo JB, et al.Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase[J].J Mol Cell Cardiol.2001, 33(5):947

二级参考文献52

  • 1睢大篔,吕忠智,于晓凤,王黎.益心口服液对大鼠急性心肌梗塞范围及血液流变学的影响[J].中国实验方剂学杂志,1996,2(3):14-16. 被引量:48
  • 2雷载权 张廷模.中华临床中药学:第一版[M].北京:人民卫生出版社,1998.1629.
  • 3Park SY, Chang SY, Yook CS, etc. New 3,4-seco-lupane-type triterpene glycosides from Acanthopanax senticosus forma inermis [ J ]. J Nat Prod, 2000,63 ( 12 ): 1630-1633.
  • 4Lu K, Otani H, Nakao Y, et al. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardiaplegia[J]. J Thorae Cardiovase Surg . 2001,121 : 137 - 148.
  • 5Nelson DW, Brown JM, Banerjee A, et 8]. Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury[J]. Surg. 1991,110:365 - 369.
  • 6Baxter GF, Yellon DM. Time course of delayed myocardial protection after transient adenosine Al-receptor activation in the rabbit[J]. J Cardiovasc Pharmacol. 1997,29:631 - 638.
  • 7Dana A, Baxter GF, Walker GM, et al. Prolonging the delayed phase of myocardial protection: rcpetive adenosine A1 receptor activation maintains rabbit myocardium in preconditioning state[J]. J Mol Cell Cardiol. 1998,31:1142 - 1149.
  • 8金惠铭 .病理生理学 [M].北京 : 人民卫生出版社 .1995, 145~ 146
  • 9Yellon DM,Baxter GF, Garcia Dorado D, et al. Ischemic preconditioning:present position and future directions[J]. Cardiovasc Res. 1998,37:21~ 33
  • 10Ikonomidis JS,Tumiati LC,Weisel RD, et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia[J]. Cardiovasc Res. 1994,28:1285~ 1291

共引文献70

同被引文献184

引证文献9

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部